Vivanza Biosciences share news, announcements and annual reports
BSE: 530057Pharmaceuticals & BiotechnologySmall Cap
Vivanza Biosciences Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1995
Last close ₹1.54up ₹0.11 (7.69%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹1.43.
30 Oct: open ₹1.50, high ₹1.60, low ₹1.50
52-week range of traded prices to 30 Oct 2026
₹1.30Low, 26 Oct 2026₹2.72High, 17 Nov 2025
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6.16 Cr4,790th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 13.57
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.41
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 2.34
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 24,333
Vivanza Biosciences board meetings
153 filed, newest first. Page 1 of 4.
Oct 2026
28 Oct · Board meeting
Meeting on 3 Nov 2026: quarterly results
Aug 2026
12 Aug · Board meeting
Meeting on 17 Aug 2026: annual general meeting
Jul 2026
28 Jul · Board meeting
Meeting on 7 Aug 2026: quarterly results
Jun 2026
15 Jun · Board meeting
Meeting on 18 Jun 2026
May 2026
4 May · Board meeting
Meeting on 7 May 2026: audited results
Apr 2026
28 Apr · Board meeting
Meeting on 4 May 2026: audited resultsNot held on this date
Feb 2026
5 Feb · Board meeting
Meeting on 12 Feb 2026: quarterly results
Nov 2025
3 Nov · Board meeting
Meeting on 11 Nov 2025: quarterly results
Sep 2025
1 Sep · Board meeting
Aug 2025
28 Aug · Board meeting
Meeting on 1 Sep 20258 Aug · Board meeting
Meeting on 13 Aug 2025: quarterly results
May 2025
6 May · Board meeting
Meeting on 12 May 2025: quarterly results and audited results
Mar 2025
20 Mar · Board meeting
Jan 2025
Oct 2024
10 Oct · Board meeting
Meeting on 17 Oct 2024: quarterly results
Aug 2024
2 Aug · Board meeting
Meeting on 8 Aug 2024: quarterly results
Jul 2024
5 Jul · Board meeting
1 Jul · Board meeting
Meeting on 5 Jul 2024
Jun 2024
Apr 2024
19 Apr · Board meeting
Meeting on 30 Apr 2024: audited results and quarterly results
Feb 2024
Jan 2024
30 Jan · Board meeting
Meeting on 6 Feb 2024: quarterly results
Oct 2023
11 Oct · Board meeting
Meeting on 26 Oct 2023: quarterly results